title: [Should insulin resistance be always treated in Polycystic Ovary Syndrome?].
authors.affiliation: Departamento de Obstetricia e Ginecologia, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brasil.
authors.forename: Jose Maria
authors.initials: JM
authors.lastname: Soares Junior
authors.affiliation: Departamento de Ginecologia e Obstetricia, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Sao Paulo, SP, Brasil.
authors.forename: Marcos Felipe Silva de
authors.initials: MF
authors.lastname: Sa
authors.affiliation: Departamento de Obstetricia e Ginecologia, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brasil.
authors.forename: Edmund Chada
authors.initials: EC
authors.lastname: Baracat
mesh_terms: D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D024821:Metabolic Syndrome / Q000209:etiology* / Q000628:therapy*; D008687:Metformin / Q000627:therapeutic use; D011085:Polycystic Ovary Syndrome / Q000150:complications*
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin